Viewing StudyNCT05841394



Ignite Creation Date: 2024-05-06 @ 6:58 PM
Last Modification Date: 2024-10-26 @ 2:57 PM
Study NCT ID: NCT05841394
Status: COMPLETED
Last Update Posted: 2023-05-03
First Post: 2023-04-22

Brief Title: A Multi-center Double-blinding Parallel and Positive-controlled Phase III Clinical Trial for Efficacy and Safety Evaluation of Ilaprazole Sodium for Injection on Prevention of Stress Ulcer Bleeding
Sponsor: Livzon Pharmaceutical Group Inc
Organization: Livzon Pharmaceutical Group Inc

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-07-16
Start Date Type: ACTUAL
Primary Completion Date: 2022-04-28
Primary Completion Date Type: ACTUAL
Completion Date: 2022-04-28
Completion Date Type: ACTUAL
First Submit Date: 2023-04-22
First Submit QC Date: April 22 2023
Study First Post Date: 2023-05-03
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-04-22
Last Update Post Date: 2023-05-03
Last Update Post Date Type: ACTUAL